Breadcrumb
Web Content Display
Web Content Display
The PhD Programme in Biology is carried out in English, in a full-time, eight-semester system.
This PhD programme covers courses representing various areas of biological sciences, including training in modern methodology and mastering skills useful in professional academic and non-academic careers. Choice of facultative classes and the possibility of gaining credits for courses offered outside of the University ensures flexibility and helps to adjust participation in courses to the individual research plan of the student.
For everyone who will be accepted for the PhD programme in Biology, a scholarship is guaranteed.
PhD students are recruited for the specific research topics offered by the faculty members. Some of the competitions listed below are held outside the OAS system (Online Application System). We kindly ask you to follow the recruitment rules described in each competition.
Each year, PhD students and their advisors/promotors write an individual research plan for a given year. Until the end of four semesters, students’ achievements are evaluated (mid-term evaluation) by the committee.
Doctoral dissertations are prepared under the supervision of a scientific staff of the Faculty of Biology (members of the Institute of Botany, Institute of Environmental Sciences or Institute of Zoology and Biomedical Research). PhD programme in Biology leads to the scientific Doctoral title in the discipline of biology. More information about the programme can be found here.
Web Content Display
Despite continued efforts and steady improvements in treatment over the past decades, ovarian cancer remains the deadliest malignancy in women. Worldwide, there are 313,959 new cases (1.6% of all cancers) and 207,252 deaths (2.1% of all cancer deaths) each year (Globocan 2020). This means that more than 66% of patients die from the disease. Recently, natural product therapy has received increased attention in an effort to improve the therapeutic index of certain antineoplastic drugs. Importantly, evidence suggests that dysregulated metabolism in cancer cells is more than a hallmark of cancer, but may be the underlying cause of the tumor [1]. We believe that in this context the bioactive compounds of sheep's milk may have an effective outcome and should be carefully considered. Sheep's milk has health-promoting properties, mainly due to the presence of bioactive and antioxidant substances that have a positive effect on metabolic processes. Sheep's milk is an important natural source of conjugated linoleic acid (CLA) and orotic acid (OA). Some studies have shown that c9,t11 CLA isomers reduce breast cancer progression in vivo by affecting hormone receptor levels and cell proliferation, while our pilot studies have shown that OA at a lower dose than sheep's milk can selectively reduce the viability of ovarian granulosa tumor cells by inducing caspase-3 activity, without negative effects on non-cancerous granulosa cells [2].
The main aim of the project is to test whether bioactive constituents of sheep's milk, such as CLA and OA, which act via metabolic pathway regulation, can be used as a powerful weapon to support standard ovarian cancer therapy.
Our proposed research will use three experimental systems to define the universal mechanism of action of the components of sheep's milk: human ovarian cell lines grown in vitro, mice with experimentally induced human ovarian cancer (in vivo) and ovarian cancer organoids derived from patient biopsies.
- experience in cell culture, molecular biology techniques like ELISA, fluorometric and/or colorimetric analysis, and proteomic analysis; - completed courses on Tissue Culture and Hormonally Active Compounds in the Environment.
[1] Gyamfi J, Kim J, Choi J. Cancer as a Metabolic Disorder. Int J Mol Sci. 2022 Jan 21;23(3):1155. doi: 10.3390/ijms23031155.
[2] Marynowicz W, Borski N, Flis Z, Ptak A, Molik E. Orotic acid induces apoptotic death in ovarian adult granulosa tumour cells and increases mitochondrial activity in normal ovarian granulosa cells. Reprod Biol. 2023 Sep;23(3):100790. doi: 10.1016/j.repbio.2023.100790.
